This live session took place on June 13th, 2019
Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem. Of the 200 state-level IDNs profiled, nearly two-thirds had CINs.
CINs are becoming the primary point of engagement for IDNs and are becoming more crucial to population health management and value-based contracts. To this end, CINs are the foundation for value-based narrow provider networks.
There are many types of IDNs, from major powerhouses within local markets to Academic medical centers, payer/provider networks and other unique arrangements.
Specifically, this webinar covered:
- What CINs are
- What makes CINs different from other physician organizations
- Their role in the overall IDN ecosystem
- Types of IDNs with specific case studies
- Implications and strategies for pharma
- Mark Cherry, Principal Analyst with Market Access
- Valerie E. Pillo, Senior Analyst with Market Access
The rapid growth and consolidation of IDNs are having a profound impact the delivery of care at both the national and regional levels. This includes greater control on HCP decisions, rising competition with traditional insurers and pharmacies as well as a greater emphasis on value based care.
Can you identify key stakeholder alignments at the local level?
Healthbase has been built to provide multi-disciplinary market access teams with the data and insight they need to understand alignments between systems – down to the individual provider level – and ascertain the market control of IDNs across US regions and patient populations.
Learn more or schedule a demo today.